Ítem
Solo Metadatos
Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment
| dc.creator | Jasti, Anil K | spa |
| dc.creator | Selmi, Carlo | spa |
| dc.creator | Sarmiento-Monroy, Juan C | spa |
| dc.creator | Vega, Daniel A | spa |
| dc.creator | Anaya, Juan-Manuel | spa |
| dc.creator | Gershwin, M Eric | spa |
| dc.date.accessioned | 2020-05-26T00:07:56Z | |
| dc.date.available | 2020-05-26T00:07:56Z | |
| dc.date.created | 2016 | spa |
| dc.description.abstract | Introduction: Guillain-Barré syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month. The etiology and pathogenesis remain largely enigmatic and the syndrome results in death or severe disability in 9–17% of cases despite immunotherapy. Areas covered: In terms of etiology, Guillain-Barré syndrome is linked to Campylobacter infection but less than 0.1% of infections result in the syndrome. In terms of pathogenesis, activated macrophages and T cells and serum antibodies against gangliosides are observed but their significance is unclear. Expert commentary: Guillain-Barré syndrome is a heterogeneous condition with numerous subtypes and recent data point towards the role of ganglioside epitopes by immunohistochemical methods. Ultimately, the syndrome results from a permissive genetic background on which environmental factors, including infections, vaccination and the influence of aging, lead to disease. © 2016 Informa UK Limited, trading as Taylor and Francis Group. | eng |
| dc.format.mimetype | application/pdf | |
| dc.identifier.doi | https://doi.org/10.1080/1744666X.2016.1193006 | |
| dc.identifier.issn | 1744666X | |
| dc.identifier.issn | 17448409 | |
| dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/24042 | |
| dc.language.iso | eng | spa |
| dc.publisher | Taylor and Francis Ltd | spa |
| dc.relation.citationEndPage | 1189 | |
| dc.relation.citationIssue | No. 11 | |
| dc.relation.citationStartPage | 1175 | |
| dc.relation.citationTitle | Expert Review of Clinical Immunology | |
| dc.relation.citationVolume | Vol. 12 | |
| dc.relation.ispartof | Expert Review of Clinical Immunology, ISSN:1744666X, 17448409, Vol.12, No.11 (2016); pp. 1175-1189 | spa |
| dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84992052404&doi=10.1080%2f1744666X.2016.1193006&partnerID=40&md5=4592c2dd34d40a63fa444b668a01d3cf | spa |
| dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
| dc.rights.acceso | Abierto (Texto Completo) | spa |
| dc.source.instname | instname:Universidad del Rosario | spa |
| dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
| dc.subject.keyword | Epitope | spa |
| dc.subject.keyword | Ganglioside antibody | spa |
| dc.subject.keyword | Autoantibody | spa |
| dc.subject.keyword | Ganglioside | spa |
| dc.subject.keyword | Aging | spa |
| dc.subject.keyword | Antibody blood level | spa |
| dc.subject.keyword | Campylobacteriosis | spa |
| dc.subject.keyword | Clinical feature | spa |
| dc.subject.keyword | Differential diagnosis | spa |
| dc.subject.keyword | Environmental factor | spa |
| dc.subject.keyword | Guillain barre syndrome | spa |
| dc.subject.keyword | Human | spa |
| dc.subject.keyword | Immunohistochemistry | spa |
| dc.subject.keyword | Immunopathogenesis | spa |
| dc.subject.keyword | Macrophage activation | spa |
| dc.subject.keyword | Nonhuman | spa |
| dc.subject.keyword | Review | spa |
| dc.subject.keyword | T lymphocyte | spa |
| dc.subject.keyword | Campylobacter jejuni | spa |
| dc.subject.keyword | Campylobacteriosis | spa |
| dc.subject.keyword | Cross reaction | spa |
| dc.subject.keyword | Genotype environment interaction | spa |
| dc.subject.keyword | Guillain barre syndrome | spa |
| dc.subject.keyword | Immunology | spa |
| dc.subject.keyword | Immunotherapy | spa |
| dc.subject.keyword | Metabolism | spa |
| dc.subject.keyword | Procedures | spa |
| dc.subject.keyword | Aging | spa |
| dc.subject.keyword | Autoantibodies | spa |
| dc.subject.keyword | Campylobacter infections | spa |
| dc.subject.keyword | Campylobacter jejuni | spa |
| dc.subject.keyword | Cross reactions | spa |
| dc.subject.keyword | Gangliosides | spa |
| dc.subject.keyword | Gene-environment interaction | spa |
| dc.subject.keyword | Guillain-barre syndrome | spa |
| dc.subject.keyword | Humans | spa |
| dc.subject.keyword | Immunotherapy | spa |
| dc.subject.keyword | Autoimmune neuropathy | spa |
| dc.subject.keyword | Guillain-barré | spa |
| dc.subject.keyword | Immune tolerance | spa |
| dc.subject.keyword | Infection and immunity | spa |
| dc.subject.keyword | Molecular mimicry | spa |
| dc.title | Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment | spa |
| dc.type | article | eng |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
| dc.type.spa | Artículo | spa |



